Estado del arte: metformina, cáncer y leucemia
Explore this paper's citation graph
Summary
Metformin, a drug used for more than 50 years, is currently the leader in the management of non-insulin dependent diabetic patients due it has mechanisms of action to regulate energy production mechanisms.
- Type
- article
- Published
- 2015-07-23
- Cited by
- 0
- References
- 60
- OpenAlex
- https://openalex.org/W1801956557
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:71107337
Keywords
Metformin, Cancer research, Angiogenesis, Metastasis, In vivo
References
- Metformin: Its emerging role in oncology
- Combined Effects of Pericytes in the Tumor Microenvironment
- The role of survivin as a new target of diagnosis and treatment in human cancer
- Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer
- Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
- Metformin and cancer.
- Metformin suppresses sonic hedgehog expression in pancreatic cancer cells.
- Evaluation of Antagonistic Effects of Metformin with Cisplatin in Gastric Cancer Cells
- AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications
- Metformin and breast cancer risk: a meta-analysis and critical literature review
- Drug-induced mitochondrial toxicity
- Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia.
- The management of patients with polycystic ovary syndrome
- Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects.
- A novel metformin derivative, HL010183, inhibits proliferation and invasion of triple-negative breast cancer cells.
- Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure
- Prediabetes diagnosis and treatment: A review.
- Changing trends in management of gestational diabetes mellitus.
- Cancer cell metabolism as new targets for novel designed therapies.
- Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells
Cited by
No citing papers recorded for this paper.
Related papers
No related papers recorded.